Education
About Us
Working with TipRanks
Follow Us
Simcere Pharmaceutical Group Limited (HK:2096)
:2096
Total Valuation
Simcere Pharmaceutical Group Limited has a market cap or net worth of HK$33.67B. The enterprise value is ―.
Market CapHK$33.67B
Enterprise Value―
Share Statistics
Simcere Pharmaceutical Group Limited has 2,595,697,500 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding2,595,697,500
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Simcere Pharmaceutical Group Limited’s return on equity (ROE) is 0.10 and return on invested capital (ROIC) is 7.66%.
Return on Equity (ROE)0.10
Return on Assets (ROA)0.06
Return on Invested Capital (ROIC)7.66%
Return on Capital Employed (ROCE)0.10
Revenue Per Employee1.01M
Profits Per Employee124.53K
Employee Count6,584
Asset Turnover0.58
Inventory Turnover2.21
Valuation Ratios
The current PE Ratio of Simcere Pharmaceutical Group Limited is 33.6. Simcere Pharmaceutical Group Limited’s PEG ratio is 3.10.
PE Ratio33.6
PS Ratio2.54
PB Ratio2.39
Price to Fair Value2.39
Price to FCF26.82
Price to Operating Cash Flow105.79
PEG Ratio3.10
Income Statement
In the last 12 months, Simcere Pharmaceutical Group Limited had revenue of 6.64B and earned 733.16M in profits. Earnings per share was 0.29.
Revenue6.64B
Gross Profit5.32B
Operating Income848.05M
Pretax Income819.88M
Net Income733.16M
EBITDA1.35B
Earnings Per Share (EPS)0.29
Cash Flow
In the last 12 months, operating cash flow was 264.23M and capital expenditures -178.49M, giving a free cash flow of 85.74M billion.
Operating Cash Flow264.23M
Free Cash Flow85.74M
Free Cash Flow per Share0.03
Dividends & Yields
Simcere Pharmaceutical Group Limited pays an annual dividend of HK$0.175, resulting in a dividend yield of 1.33%
Dividend Per ShareHK$0.175
Dividend Yield1.33%
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.68
52-Week Price Change103.10%
50-Day Moving Average13.10
200-Day Moving Average10.05
Relative Strength Index (RSI)52.38
Average Volume (3m)10.62M
Important Dates
Simcere Pharmaceutical Group Limited upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend DateJun 18, 2025
Financial Position
Simcere Pharmaceutical Group Limited as a current ratio of 2.00, with Debt / Equity ratio of 17.00%
Current Ratio2.00
Quick Ratio1.79
Debt to Market Cap0.06
Net Debt to EBITDA-0.54
Interest Coverage Ratio12.19
Taxes
In the past 12 months, Simcere Pharmaceutical Group Limited has paid 86.71M in taxes.
Income Tax86.71M
Effective Tax Rate0.11
Enterprise Valuation
Simcere Pharmaceutical Group Limited EV to EBITDA ratio is 11.94, with an EV/FCF ratio of 25.65.
EV to Sales2.43
EV to EBITDA11.94
EV to Free Cash Flow25.65
EV to Operating Cash Flow11.59
Balance Sheet
Simcere Pharmaceutical Group Limited has HK$2.68B in cash and marketable securities with HK$1.23B in debt, giving a net cash position of HK$1.45B billion.
Cash & Marketable SecuritiesHK$2.68B
Total DebtHK$1.23B
Net CashHK$1.45B
Net Cash Per ShareHK$0.56
Tangible Book Value Per ShareHK$2.33
Margins
Gross margin is 81.00%, with operating margin of 12.78%, and net profit margin of 11.05%.
Gross Margin81.00%
Operating Margin12.78%
Pretax Margin12.36%
Net Profit Margin11.05%
EBITDA Margin20.35%
EBIT Margin17.12%
Analyst Forecast
The average price target for Simcere Pharmaceutical Group Limited is HK$16.30, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price TargetHK$16.30
Price Target Upside24.43% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast―
EPS Growth Forecast―